Cinacalcet

Cinacalcet is used in the management of hyperparathyroidism and disorders of calcium and phosphate balance. This page provides information to support the safe prescribing, monitoring and ongoing management of cinacalcet therapy.

Bedfordshire, Luton and Milton Keynes

Cinacalcet for the management of Primary hyperparathyroidism in patients with severe hypercalcaemia awaiting surgery or deemed unfit for surgical management – Shared Care Guideline (pdf)

The Shared Care Guideline below was developed by Hertfordshire and West Essex and has been ratified for use in Bedfordshire, Luton and Milton Keynes for patients receiving care from East and North Hertfordshire Teaching NHS Trust.

Cinacalcet for Use in Secondary Hyperparathyroidism in Adults with End Stage Kidney Disease (ESKD) Requiring Renal Replacement Therapy – Shared Care Guideline (pdf)

Cambridgeshire and Peterborough

Cinacalcet for the management of primary and secondary hyperparathyroidism – Shared Care Guidance (pdf)